Stony Brook Southampton Hospital recently received the American Heart Association and American Stroke Association’s Get With The Guidelines Target: Stroke Honor Roll Elite Plus Gold Plus Quality Achievement Award.
“We are pleased to recognize Stony Brook Southampton Hospital for their commitment to stroke care,” Lee H. Schwamm, national chairperson of the Quality Oversight Committee and executive vice chair of neurology and director of acute stroke services at Massachusetts General Hospital, said in a press release. “Research has shown that hospitals adhering to clinical measures through the Get With The Guidelines quality improvement initiative can often see fewer readmissions and lower mortality rates.”
Stony Brook University Hospital also received the Get With The Guidelines Target: Stroke Honor Roll Elite Gold Plus Quality Achievement Award, recognizing Stony Brook Medicine’s “commitment to ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines based on the latest scientific evidence,” the release said.
Stony Brook Southampton Hospital and Stony Brook University Hospital each earned an award by meeting specific quality achievement measures for the diagnosis and treatment of stroke patients at a set level for a designated period. These measures include: evaluation of the proper use of medications and other stroke treatments aligned with the most up-to-date; evidence-based guidelines with the goal of speeding recovery; and reducing death and disability for stroke patients. Before discharge, patients should also receive education on managing their health, schedule a follow-up visit, as well as other care transition interventions.
“Stony Brook Medicine is dedicated to improving the quality of care for our stroke patients by implementing the American Heart Association’s Get With The Guidelines-Stroke initiative,” Kristie Golden, associate director of operations and neurosciences at Stony Brook University Hospital. “The tools and resources provided help us track and measure our success in meeting evidenced-based clinical guidelines developed to improve patient outcomes.”
Stony Brook Southampton Hospital additionally received the association’s Target: StrokeSM Elite Plus award. To qualify for this recognition, hospitals must meet quality measures developed to reduce the time between the patient’s arrival at the hospital and treatment with the clot-buster tissue plasminogen activator, or tPA, the only drug approved by the U.S. Food and Drug Administration to treat ischemic stroke.
“According to the American Heart Association/American Stroke Association, stroke is the number-five cause of death and a leading cause of adult disability in the United States,” the release said. “On average, someone in the United States suffers a stroke every 40 seconds and nearly 795,000 people suffer a new or recurrent stroke each year.”
For more information, visit stonybrookmedicine.edu.